MED — Medcom Tech SA Share Price
- €8.92m
- €26.09m
- €24.92m
- 46
- 39
- 76
- 53
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 31.33 | ||
Price to Tang. Book | 189.37 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.33 | ||
EV to EBITDA | 17.18 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 2.77% | ||
Return on Equity | -134.84% | ||
Operating Margin | 1.65% |
Financial Summary
Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | 24.27 | 22.26 | 18.56 | 22.82 | 24.92 | n/a | n/a | -2.69% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Medcom Tech SA is a Spain-based company primarily engaged in the distribution and wholesale of technologically advanced products in the areas of Orthopedics, Biologicals, Traumatology and Neurosurgery in Spain, Portugal and Italy. The Company comprises of four departments: Department of Goods, Department of medical professionals, Department of Administration and Logistics and Department of Finance. The product range offered by the Company includes devices treating spine disorders (Dervical, Dorsal of Lumbar pathologies), thousands of patented prosthetic implants for surgery, implants used to synthesize fractures, prosthetic implants for upper limb and foot, as well as medical instruments and precision accessories, among others. The Company also has a license to distribute the patents of such companies as United Ortopedic Corporation, K2M, Bone Support, PAN Medical Ltd, Ranier Technology Ltd, Ascencion Orthopedics and Extremity Medical LLC, among others.
Directors
- Joan Sagales Manas CHM
- Jordi Llobet Perez SEC
- Nicolas Ayuso Moragas DRC
- Josep Maria Coronas Guinart DRC
- Nestor Oller Bube DRC
- Alejandro Roca de Vinals Delgado DRC
- Salvador Torrens Iglesias DRC
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- January 1st, 1970
- Public Since
- March 1st, 2010
- No. of Employees
- 111
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Madrid Stock Exchange
- Shares in Issue
- 12,921,204

- Address
- C/ Catalunya, 83-85, VILADECANS, 08840
- Web
- http://www.medcomtech.es/es/
- Phone
- +34 934803374
- Auditors
- Grant Thornton
Upcoming Events for MED
Similar to MED
Prim SA
Madrid Stock Exchange
FAQ
As of Today at 18:14 UTC, shares in Medcom Tech SA are trading at €0.69. This share price information is delayed by 15 minutes.
Shares in Medcom Tech SA last closed at €0.69 and the price had moved by +2.99% over the past 365 days. In terms of relative price strength the Medcom Tech SA share price has underperformed the FTSE Global All Cap Index by -0.93% over the past year.
There is no consensus recommendation for this security.
Find out moreMedcom Tech SA does not currently pay a dividend.
Medcom Tech SA does not currently pay a dividend.
Medcom Tech SA does not currently pay a dividend.
To buy shares in Medcom Tech SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €0.69, shares in Medcom Tech SA had a market capitalisation of €8.92m.
Here are the trading details for Medcom Tech SA:
- Country of listing: Spain
- Exchange: MCE
- Ticker Symbol: MED
Based on an overall assessment of its quality, value and momentum Medcom Tech SA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medcom Tech SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +64.63%.
As of the last closing price of €0.69, shares in Medcom Tech SA were trading +51.12% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medcom Tech SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.69.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Medcom Tech SA's management team is headed by:
- Joan Sagales Manas - CHM
- Jordi Llobet Perez - SEC
- Nicolas Ayuso Moragas - DRC
- Josep Maria Coronas Guinart - DRC
- Nestor Oller Bube - DRC
- Alejandro Roca de Vinals Delgado - DRC
- Salvador Torrens Iglesias - DRC